+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aliskiren (CAS 173334-57-1) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4173891
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Aliskiren. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Aliskiren global market report's key points:

  • Aliskiren description, applications and related patterns
  • Aliskiren market situation
  • Aliskiren manufacturers and distributors
  • Aliskiren prices
  • Aliskiren end-users
  • Aliskiren downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Aliskiren end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Aliskiren market trends and forecast, distinguish Aliskiren manufacturers and suppliers.

The sixth chapter provides Aliskiren prices data.

The seventh chapter analyses Aliskiren downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. ALISKIREN GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. ALISKIREN APPLICATIONS

3. ALISKIREN MANUFACTURING METHODS

4. ALISKIREN PATENTS

5. ALISKIREN MARKET WORLDWIDE
5.1. Global Aliskiren market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Aliskiren
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Aliskiren
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. ALISKIREN MARKET PRICES
  • Europe
  • Asia
  • North America
7. ALISKIREN END-USE SECTOR

Related Topics

Related Reports

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems - Product Image

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems

  • Book
Berbamine (CAS 478-61-5) Global Market Research Report 2024 - Product Image

Berbamine (CAS 478-61-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Budralazine (CAS 36798-79-5) Global Market Research Report 2024 - Product Image

Budralazine (CAS 36798-79-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Amyl Nitrite Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Amyl Nitrite Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From

About the Aliskiren Market

Aliskiren is a direct renin inhibitor used in the treatment of hypertension and other cardiovascular diseases. It works by blocking the action of renin, an enzyme that helps regulate blood pressure. Aliskiren is typically prescribed in combination with other antihypertensive medications, such as diuretics, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. It is available in both oral and intravenous formulations. Aliskiren has been shown to be effective in reducing blood pressure and improving cardiovascular outcomes. It is generally well-tolerated, with few side effects. However, it is not recommended for use in patients with renal impairment or diabetes. The aliskiren market is highly competitive, with several major pharmaceutical companies offering products. These include Novartis, Merck, Pfizer, and Sanofi. Other companies, such as Daiichi Sankyo and Takeda, also offer aliskiren-based products. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.